Nonnucleoside reverse transcriptase inhibitors
Affiliations
- PMID: 11364757
Item in Clipboard
Nonnucleoside reverse transcriptase inhibitors
AIDS Clin Care.
1997 Oct.
Abstract
AIDS: Nonnucleoside transcriptase inhibitors (NNRTIs) are potent antiretroviral agents that can successfully be used in appropriate HIV/AIDS triple-therapy regimens, although resistance can develop rapidly. The two primary advantages of initiating NNRTIs therapy are that it delays the use of protease inhibitors and the NNRTIs regimen is easier to adhere to and can be given once per day. Nevirapine and delavirdine, two NNRTIs that have been approved for clinical use, are examined, and loviride, efavirenz, and HBY 097, currently under development, are discussed. The advantages, disadvantages, and pharmacologic characteristics of each drug are highlighted.
Similar articles
-
Choosing the right initial antiretroviral regimens.GMHC Treat Issues. 1999 Feb;13(2):7-10. GMHC Treat Issues. 1999. PMID: 11366117
-
Antiviral update.PI Perspect. 1996 Nov;(No 20):8-9. PI Perspect. 1996. PMID: 11363972
-
Rescue me.Res Initiat Treat Action. 1998 Aug;4(5):10. Res Initiat Treat Action. 1998. PMID: 11365705
-
Combination antiretroviral therapy for HIV infection.Am Fam Physician. 1998 Jun;57(11):2789-98. Am Fam Physician. 1998. PMID: 9636341 Review.
-
Antiretroviral therapies.Clin Podiatr Med Surg. 1998 Apr;15(2):227-39. Clin Podiatr Med Surg. 1998. PMID: 9576051 Review.
Cited by
-
The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.Paediatr Drugs. 2001;3(9):681-702. doi: 10.2165/00128072-200103090-00006. Paediatr Drugs. 2001. PMID: 11688599 Review.
-
AIDS at 40th: The progress of HIV treatment in Japan.Glob Health Med. 2022 Feb 28;4(1):1-8. doi: 10.35772/ghm.2021.01120. Glob Health Med. 2022. PMID: 35291198 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical